plans for expanding future drug price negotiations, including by enabling Medicare to negotiate the prices of more drugs more quickly
Support the expansion of Medicare's ability to negotiate the prices of more prescription drugs more quickly.
Occurrences
Evidence
Senators Catherine Cortez Masto, Ron Wyden, Peter Welch, and Ruben Gallego announced a Democratic plan for lowering prescription drug costs, including by enabling Medicare to negotiate the prices of more drugs more quickly.
Cortez Masto, Klobuchar, and Welch introduced the SMART Prices Act, which would expand Medicare negotiation of drug prices, more than double the number of prescription drugs Medicare must negotiate to a minimum of 50 per year, and allow negotiation five years after FDA approval for the costliest drugs and biologics.
Assessments
Cortez Masto has supported and introduced legislation to expand Medicare drug-price negotiation to more drugs on a faster timeline, including the SMART Prices Act and a 2026 Democratic plan. However, the promised policy expansion has not been enacted into federal law based on the provided evidence. Because she made a serious legislative effort but the outcome remains undelivered, this should be scored as not fulfilled with an effort badge rather than partial delivery.